Back to Results
First PageMeta Content
Pharmacology / Drug discovery / Epidemiology / Clinical research / Pharmaceutical industry / European Federation of Pharmaceutical Industries and Associations / Orphan drug / Rare disease / EuropaBio / Health / Pharmaceutical sciences / Science


Document Date: 2011-08-23 10:19:43

Open Document

File Size: 175,76 KB

Share Result on Facebook

Company

European Biopharmaceutical Enterprises / OMPs / Health Care Systems / /

Continent

Europe / /

Country

France / United States / /

Currency

EUR / /

/

IndustryTerm

biotechnology associations / biopharmaceutical / pharmaceutical industry federation / biotechnology / pharmaceutical industry / biotechnology products / diagnostic tools / health technology assessment / healthcare policies / manufacturing / health systems / biotechnology arm / care systems / biopharmaceutical industry / medicinal products / orphan medicinal products / /

MedicalCondition

each rare disease / specific diseases / Rare Diseases / disease / rare cancers / chronic / musculoskeletal disorders / diseases / /

Organization

office of Health Economics / Joint EBE/EuropaBio Task Force on Rare Diseases / European Association for Bioindustries / Joint Task Force / EBE/EuropaBio Task Force on Rare Diseases & Orphan Medicinal Products / European Union / /

Person

Emmanuel Chantelot / /

/

Position

driver / Executive Director / Director / EuropaBio l.lacaine@europabio.org / /

ProgrammingLanguage

EC / /

PublishedMedium

Health Economics / /

Technology

biotechnology / /

SocialTag